Abstract 
of prostaglandin particularly prostaglandin E2 [3] [4] [5] . However in the last few years there has been considerable interest in the use of misoprostol for cervical ripening and labour induction [6] [7] [8] [9] [10] [11] . Results of published trial suggest that misoprostol was both safe and effective but optimum dose and timing of administration of this medication for labour induction have not been clearly determined 12 . Misoprostol is a new synthetic analogue of prostaglandin E1. It has several advantages over other prostaglandins which includes low cost, easy storage at room temperature and favorable side-effects profiles 13 . Vaginal misoprostol has been extensively studied and a consensus exists as to its efficacy [14] [15] [16] . The aim of this study is to compare safety and efficacy of different doses of misoprostol in termination of IUD cases.
Materials and methods:
This prospective randomized controlled trial was conducted jointly in the Dept of obs and gynae, BSMMU and Khulna Medical College Hospital during the period from July to December, 2011. In this study total 60 IUFD cases of 28 to 42 weeks or more were included. Primi or multigravida, singleton pregnancy, cephalic or breech presentation and Bishop's score 5 or less were the inclusion criteria. Grand multiparas, women having history of previous caesarean section or myomectomy, transverse lie, placenta praevia were excluded from the study. Women having coagulopathy, hypersensitivity to prostaglandin and asthma were also excluded. On admission detailed history was taken and clinical examination was done and confirmation of IUFD was done using ultrasonogram. After proper counseling an informed written consent was taken from each patient. Per vaginal examination was done for evaluation of Bisop's score. The selected patients were randomly divided into two groups for termination using two different doses of misoprostol. For randomization a sequentially numbered sealed envelopes were used before termination. Among 60 patients 30 (group -1) received 50mcg of misoprostol 6 hourly and 30 patients received (group -2) 100mcg of misoprostol 8 hourly per vaginally.
In group -1 50mcg of misoprostol was administered 6 hourly intra-vaginally and in group-2 100mcg of misoprostol was administered 8 hourly up to starting of effective lalour pain. Then the total number of required doses to complete the procedure was recorded in the data collection sheet. Induction delivery time, number of delivery within 24 hours, mode of delivery, side-effects and complications of misoprostol were recorded. Pulse, BP, Temperature were noted every 4 hourly. SPSS (version 12.0) statistical software was uses for data analysis. The result was expressed as the mean (±SD), percentage and range. Comparison was done using t test and chi square test, p value <0.05 was considered significant. Table 1 shows the socio -demographic condition of the study subject. Mean age of group-1 and group -2 was 24.53 ± 5.21 and 26.30±5.10 years respectively (P = .29). Mean gestational age of group-1 and group -2 was 34.67 ± 3.67 and 33.83±4.11 weeks respectively (P = 0.4), there were no statistically significant difference between two groups regarding age and period of gestation and gravida. Table II shows the Bishop's score of the study subjects. In group-1 Bishop's score was 2-5 in 8(26.67%) cases and 4-5 in 22(73.33%) cases. In group-2 Bishop score was 2-3 in 10(33.33%) and 4-5 in 20(66.67%) cases. Table III shows the comparison of out-come between 2 groups. Induction delivery time, mean+SD was 21.7±9.47 and 26.17±11.17 hours respectively in group-1 and group-2, (P=0.10). Number of doses required was, mean±SD 2.67±0.9 in group-1 and 2.08±0.81 in group-2, the difference was statistically significant (P<0.006). Delivery within 24 hours occurred in 20(66.67%) cases in group-1 and in 16(53.33%) in group-2. Table IV shows the mode of delivery between 2 groups. Out of 60 cases of IUD, all were delivered vaginally in both groups. Table V shows the side effects misoprostol. Nausea, vomiting were present 16.67% and 10% in group-1 and 33.33% and 16.67% in group-2 respectively. In both groups most of the cases had no side effect. Table VI shows the comparison of complication between 2 groups. In both the groups most of the patients did not develop any complications. In group-1 there was hyperstimulation in 2(6.67%) cases and tachysystole in 1(3.33%) case. In group-2 hyperstimulation and tachysystole developed in 4(13.33%) and 2(6.67%) cases respectively. 
Results:

Discussion:
The use of prostaglandins in termination of intrauterine fetal death has undergone a rapid evoluation. Prostaglandins had an effect on myometrial contractility and they also accelerate cervical ripening. Misoprostol, synthetic analogue of prostaglandin E1. It has several advantages over other prostaglandins which include low cost, easy storage at room temperature and favorable side effect profile. This study was aimed to evaluate the safety and efficacy of different doses of misoprostol in termination of IUFD cases.
In this study delivery within 24 20 .
In previous studies a large range of doses of intravaginal and sublingual misoprostol used for induction were described, ranging from 100mcg 12 hourly to400mcg 3 hourly 18, [20] [21] [22] [23] . Furthermore different doses were used at different gestational ages. One study recommended the following doses of misoprostol in missed abortion or IUD cases; 200mcg 6 hourly for gestational age of 13-17; 100mcg 6 hourly 18 . But in the present study there was no diarrhea, shivering. Studies showed that the use of misoprostol was associated with an increased incidence of tachysystole (defined as 6 or more uterine contraction in 10 minutes for two 10 minutes period) and hyperstimulation (uterine contraction lasting more than 90 seconds or more 5contraction in 10 minutes). The incidence of hyperstimulation varies between 1 and 10 percent. In this study in group-1 there was hyperstimulation in 2(6.67%) cases and tachysystole in 1(3.33%) case. In group-2 hyperstimulation and tachysystole developed in 4(13.33%) and 2(6.67%) cases respectively. In this study no patient developed serious complications like DIC or rupture of uterus. In some studies more complications were found compared to the present study [24] [25] [26] [27] .
In this study all IUFD cases delivered vaginally, no operative interference required.
Conclusion:
Both 50mcg and 100mcg intravaginal misoprostol are safe and effective in termination of intrauterine foetal death.But50mcg is safer as side-effects and complications were less, induction delivery time was shorter in case of 50mcg than 100mcg. Delivery within 24 hours was higher in group -1. So 50 mcg intravaginal misoprostol was more safe and effective in termination of IUD cases.
